Shivendra Singh, Ahmed Abu-Zaid, Hongjian Jin, Jie Fang, Qiong Wu, Tingting Wang, Helin Feng, Waise Quarni, Ying Shao, Lily Maxham, Alireza Abdolvahabi, Mi-Kyung Yun, Sivaraja Vaithiyalingam, Haiyan Tan, John Bowling, Victoria Honnell, Brandon Young, Yian Guo, Richa Bajpai, Shondra M Pruett-Miller, Gerard C Grosveld, Mark Hatley, Beisi Xu, Yiping Fan, Gang Wu, Eleanor Y Chen, Taosheng Chen, Peter W Lewis, Zoran Rankovic, Yimei Li, Andrew J Murphy, John Easton, Junmin Peng, Xiang Chen, Ruoning Wang, Stephen W White, Andrew M Davidoff, Jun Yang
Chimeric transcription factors drive lineage-specific oncogenesis but are notoriously difficult to target. Alveolar rhabdomyosarcoma (RMS) is an aggressive childhood soft tissue sarcoma transformed by the pathognomonic Paired Box 3-Forkhead Box O1 (PAX3-FOXO1) fusion protein, which governs a core regulatory circuitry transcription factor network. Here, we show that the histone lysine demethylase 4B (KDM4B) is a therapeutic vulnerability for PAX3-FOXO1+ RMS. Genetic and pharmacologic inhibition of KDM4B substantially delayed tumor growth...
July 13, 2022: Science Translational Medicine